CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $58,826
- in 14 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$58,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-06-05 | MITCHELL WILLIAM M Director | Other acquisition · Options to buy Common Stock | +100,000 | 412,000 | ||
| 2012-06-05 | PIANI RICHARD Director | Other acquisition · Options to buy Common Stock | +100,000 | 424,608 | ||
| 2012-06-05 | Equels Thomas K. Exec Vice Chairman of Board | Other acquisition · Options to buy Common Stock | +100,000 | 700,000 | ||
| 2012-06-05 | CARTER WILLIAM A CEO | Other acquisition · Options to buy Common Stock | +100,000 | 6,865,378 | ||
| 2012-06-05 | Springate Wayne S. Senior VP of Operations | Other acquisition · Options to buy Common Stock | +50,000 | 188,900 | ||
| 2012-06-05 | Dickey Robert IV Senior Vice President | Other acquisition · Options to Buy Common Stock | +50,000 | 200,000 | ||
| 2012-05-18 | STRAYER DAVID R Medical Director | Purchase | +44,900 | $0.26 | $11K | 280,932 |
| 2012-05-17 | STRAYER DAVID R Medical Director | Purchase | +5,100 | $0.26 | $1K | 236,032 |
| 2012-05-10 | KIANI IRAJ EGHBAL Director | Other acquisition | +11,062 | $2.26 | $25K | 257,333 |
| 2012-05-10 | KIANI IRAJ EGHBAL Director | Other acquisition | +5,208 | $2.40 | $12K | 262,541 |
| 2012-04-13 | STRAYER DAVID R Medical Director | Other acquisition · Options to buy Common Stock | +10,000 | 190,000 | ||
| 2012-04-13 | CARTER WILLIAM A CEO | Other acquisition · Options to buy Common Stock | +10,000 | 6,765,378 | ||
| 2011-12-22 | Bernhardt Charles Thomas III Chief Financial Officer | Other acquisition · Options to buy Common Stock | +100,000 | 200,000 | ||
| 2011-09-23 | Cavalli Ralph Christopher VP, Quality Control | Other acquisition · Options to buy Common Stock | +40,000 | 60,000 | ||
| 2011-07-15 | CARTER WILLIAM A CEO | Other acquisition · Options to buy Common Stock | +500,000 | 7,256,574 | ||
| 2011-06-24 | Equels Thomas K. General Counsel | Other acquisition · Options to buy Common Stock | +300,000 | 1,091,196 | ||
| 2011-05-31 | Springate Wayne S. VP of Operations | Purchase · Options to buy Common Stock | +90,000 | 138,900 | ||
| 2011-03-01 | Lander Russel J VP of Process/QualityAssurance | Purchase | +25,000 | $0.46 | $12K | 182,983 |
| 2011-03-01 | Lander Russel J VP of Process/QualityAssurance | Purchase | +25,000 | $0.46 | $11K | 207,983 |
| 2010-12-22 | CARTER WILLIAM A CEO | Purchase · Options to buy Common Stock | +73,728 | 6,756,574 |
Page 27 of 33 · 653 trades